期刊： JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2021; 48 (5)
Recombinant human erythropoietin (rHuEPO) is effective in managing chronic kidney disease and chemotherapy-induced anemia. However, hyporesponsiveness......
期刊： JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, ; ()
The main objective of this article is to propose the closed-form solution of one-compartment pharmacokinetic model with simultaneous first-order and M......
期刊： JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2020; 47 (1)
Cancer metastasis is the main cause of death in various types of cancer. However, in the field of pharmacometrics, cancer disease progression models f......
期刊： JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2020; 47 (2)
Background Pharmacokinetic/pharmacodynamic (PK/PD) modeling has made an enormous contribution to intravenous anesthesia. Because of their altered phys......
期刊： JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2019; 46 (6)
The effects of contezolid (MRX-I, an oxazolidinone antibacterial agent) on cardiac repolarization were evaluated retrospectively using a population mo......
期刊： JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2019; 46 (5)
Sildenafil (REVATIO (R)) was approved for the treatment of adult Pulmonary Arterial Hypertension (PAH) in the US and the EU. A pediatric study has bee......
期刊： JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2018; 45 (5)
Drugs with an additional endogenous source often exhibit simultaneous first-order and Michaelis-Menten elimination and are becoming quite common in ph......
期刊： JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2022; 49 (2)
Pharmacokinetics is a scientific branch of pharmacology that describes the time course of drug concentration within a living organism and helps the sc......
期刊： JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017; 44 (5)
Conventional maximum tolerated doses (MTD) in chemotherapy are recently challenged by an alternative dosing method with low doses and high dosing freq......
